Activbiotics focuses on treatment for inflammatory diseases and bacterial infections.

Products: 

Rifalazil: In a Phase 3 clinical trial for intermittent claudication associated with peripheral arterial disease (PAD).

(PAD is a result of atherosclerosis of the arteries located in the lower extremities. Symptoms include pain, cramping or fatigue in the lower extremities brought on by exertion or walking .)

M40403 is a synthetic small molecule designed to mimic the function of a naturally occurring enzyme that plays a role in several inflammatory disease states. A Phase 2 clinical trial of M40403 for the prevention of post-operative ileus (POI), a temporary impairment of bowel function following surgery. Other clinical programs, include the identification of product candidates for the treatment of inflammatory diseases and bacterial infections from its proprietary antibacterial and SOD mimetic libraries.